Cargando…
MON-315 Transcription Factor NRF2 May Serve as a Master Regulator of Immune Modulation and Lung Cancer Progression
Lung cancer contributes to the highest rates of cancer-related deaths world-wide. Approximately 80% of lung cancers are non-small cell lung cancers (NSCLC), and adenocarcinomas (adenoCa) comprise about half of these. Importantly, >20% of lung adenoCa harbor mutations in transcription factor NRF2...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550722/ http://dx.doi.org/10.1210/js.2019-MON-315 |